Malcolm Ward - Proteome Sciences Insider

Proteome Sciences plc -- UK Stock  

GBp 3.76  0.43  10.26%

Chief Technical Officer of London Research Facility

Dr. Malcolm Ward is Chief Technical Officer London Research Facility of Proteome Sciences PLC. Malcolm Ward joined Proteome Sciences plc in May 2001 having previously worked for GlaxoWellcome for 12 years, in protein mass spectrometry. He was involved in the establishment of the new leading edge protein separation and mass spectrometry facility at the Institute of Psychiatry, Kings College London. His research team is involved in biomarker discovery, validation and assay development. His academic qualifications include a MS in Molecular Biology from the University of Hertfordshire in 1996 and a Graduateship from the Royal Society of Chemistry in 1992. He obtained a PhD in Applied Proteomics at Kings College, London in 2009..
  Executive Since 2011      
44 20 7043 2116  http://www.proteomics.com

Management Efficiency

The company has return on total asset (ROA) of (20.17) % which means that it has lost $20.17 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (16.4) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 8.93 M in total debt. Proteome Sciences plc has Current Ratio of 0.38 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Found 6 records

EXECUTIVE Since

Simon ThornRedx Pharma Plc
N/A
Tony BunnSareum Holdings plc
N/A
Hussein ArkhaghaHikma Pharmaceuticals PLC
2013
Peter SpeirsHikma Pharmaceuticals PLC
2012
Bassam KanaanHikma Pharmaceuticals PLC
2014
Paul MussendenBTG plc
2010

Entity Summary

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. The company was incorporated in 1993 and is headquartered in London, the United Kingdom. Proteome Sciences operates under Medical Laboratories Research classification in UK and traded on London Stock Exchange. It employs 36 people.Proteome Sciences plc (PRM) is traded on London Stock Exchange in UK. It is located in Hamilton House and employs 36 people.

Proteome Sciences plc Leadership Team

William Dawson, Director
Roger McDowell, Director
Christopher Pearce, Director
Ian Pike, Director, Ph.D
Richard Dennis, Executive
Malcolm Ward, Executive
Martin Diggle, Director
Jeremy Haigh, CEO
Josef Schwarz, Executive, MBA
Ursula Ney, Director, Ph.D
Glenn Barney, VP
Gee Chee, Director, Ph.D
Geoffrey Ellis, Director

Stock Performance Indicators

Did you try this?

Run Cryptocurrency Correlation Now
   

Cryptocurrency Correlation

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges
View All  Next Launch Cryptocurrency Correlation

Trending Equities

Currently Active Assets on Macroaxis
V   
 NYQ 
Sold over 20 shares of
a day ago
Traded for 124.2
CRM   
 NYQ 
Purchased over 20 shares of
a day ago
Traded for 122.82
MSFT   
 NMS 
Purchased over 30 shares of
a day ago
Traded for 95.0
C   
 NYQ 
Purchased over 40 shares of
a day ago
Traded for 70.0
TWTR   
 NYQ 
Purchased over 90 shares of
a day ago
Traded for 31.91
GM   
 NYQ 
Purchased over 70 shares of
a day ago
Traded for 37.61
Additionally take a look at Your Equity Center. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.